Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes

Details for Australian Patent Application No. 2005321904 (hide)

Owner MannKind Corporation

Inventors Liu, Xiping; Smith, Kent Andrew; Bot, Adrian Ion

Agent Davies Collison Cave

Pub. Number AU-B-2005321904

PCT Pub. Number WO2006/071989

Priority 60/640,402 29.12.04 US

Filing date 29 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 12 July 2012

International Classifications

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61K 39/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/071989 Priority application(s): WO2006/071989

12 July 2012 Application Accepted

  Published as AU-B-2005321904

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005321905-Methods to bypass CD+4 cells in the induction of an immune response

2005321903-Thienopyrimidine derivatives as phosphodiesterase 10 inhibitors